Alcon Expands Drug Portfolio with GSK and Origenis Deals
By Helen Scrutton
Pharma Deals Review: Vol 2008 Issue 101 (Table of Contents)
Published: 14 Oct-2008
DOI: 10.3833/pdr.v2008.i101.117 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Alcon has signed two deals to expand its future drug portfolio, that includes gaining a licence for troubled GlaxoSmithKline product, cilomilast...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS